ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,571Medicare Part D Prescriptions Filled, Including Refills

Rank: 236 out of 6969

$1.11M Total Retail Price of All Prescriptions

Rank: 118 out of 6969

492 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
89% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

23% of this provider’s 492 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

2% of this provider’s 11,096 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

31% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$88 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
SIMVASTATIN 804 699 1 1
AMLODIPINE BESYLATE 488 446 2 4
METOPROLOL SUCCINATE 444 390 3 22
METFORMIN HCL 419 378 4 7
NAPROXEN 393 351 5 62
LEVOTHYROXINE SODIUM 337 279 6 5
OMEPRAZOLE 305 275 7 6
GABAPENTIN 305 266 7 17
BENAZEPRIL-HYDROCHLOROTHIAZIDE 269 238 9 132
SPIRIVA 258 228 10 66
DIOVAN HCT 253 235 11 57
FLUOXETINE HCL 245 216 12 43
ADVAIR DISKUS 244 218 13 45
FUROSEMIDE 242 225 14 10
ZOLPIDEM TARTRATE 235 215 15 16
CARVEDILOL 229 209 16 25
ATORVASTATIN CALCIUM 219 198 17 11
BENAZEPRIL HCL 207 185 18 18
HYDROCODONE-ACETAMINOPHEN 205 182 S3 19 3
TAMSULOSIN HCL 198 192 20 23
LOSARTAN-HYDROCHLOROTHIAZIDE 195 183 21 53
ALENDRONATE SODIUM 170 170 22 14
JANUVIA 158 146 23 41
HYDROCHLOROTHIAZIDE 155 141 24 8
GLYBURIDE 152 128 R 25 54
ALLOPURINOL 146 125 26 35
AMOX TR-POTASSIUM CLAVULANATE 125 104 27 194
CLOPIDOGREL 119 101 28 48
AMLODIPINE BESYLATE-BENAZEPRIL 115 86 29 91
PREDNISONE 113 101 30 70
LANTUS SOLOSTAR 105 83 31 154
ACETAMINOPHEN-CODEINE 99 97 S3 32 73
PLAVIX 99 83 32 68
RANITIDINE HCL 99 70 32 46
SYMBICORT 98 93 35 149
JALYN 83 83 36 339
CRESTOR 83 71 36 39
NEXIUM 83 83 36 52
LOSARTAN POTASSIUM 81 73 39 12
ATENOLOL 79 65 40 9
AVODART 77 77 41 108
METHOTREXATE 75 60 42 385
LANTUS 72 55 43 50
LISINOPRIL 72 59 43 2
JANUMET 71 56 45 138
SERTRALINE HCL 69 61 46 38
GLYBURIDE-METFORMIN HCL 68 65 R 47 92
DOXEPIN HCL 67 64 48 319
METOPROLOL TARTRATE 65 52 49 13
PROAIR HFA 65 56 49 33
LISINOPRIL-HYDROCHLOROTHIAZIDE 64 49 51 28
CLOTRIMAZOLE 62 53 52 259
DIOVAN 59 59 53 26
LOVASTATIN 58 35 54 15
PEN NEEDLE 57 53 55 196
BENICAR HCT 57 57 55 176
EXELON 57 57 55 157
NAMENDA 56 56 58 51
ACYCLOVIR 53 38 59 237
LIPITOR 52 51 60 89
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 9, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.